Bionano Genomics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNGO and other ETFs, options, and stocks.

About BNGO

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.

CEO

Robert Erik Holmlin

CEORobert Erik Holmlin

Employees

100

Employees100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2003

Founded2003

Employees

100

Employees100

BNGO Key Statistics

Market cap

17.33M

Market cap17.33M

Price-Earnings ratio

-0.04

Price-Earnings ratio-0.04

Dividend yield

—

Dividend yield—

Average volume

2.27M

Average volume2.27M

High today

$1.85

High today$1.85

Low today

$1.78

Low today$1.78

Open price

$1.81

Open price$1.81

Volume

913.41K

Volume913.41K

52 Week high

$30.52

52 Week high$30.52

52 Week low

$1.50

52 Week low$1.50

BNGO News

TipRanks 3d

BioNano Genomics Completes $9 Million Public Offering

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Seeking Alpha 4d

Bionano Genomics slides after pricing $10M equity offering

Healthcare On the Move Bionano Genomics slides after pricing $10M equity offering Sep. 16, 2025 9:28 AM ET Bionano Genomics, Inc. (BNGO) Stock By: Preeti Singh...

TipRanks 5d

Bionano Genomics issues book series related to OGM in chromoanagenesis research

Bionano Genomics (BNGO) announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome rearrangement kn...

More BNGO News

TipRanks 6d

Bionano Genomics announces CMS posted preliminary payment determination for OGM

Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics (BNGO), announced that Centers for Medicare & Medicaid Services, CMS, posted the preliminary...

People also own

Based on the portfolios of people who own BNGO. This list is generated using Robinhood data, and it’s not a recommendation.